当前位置:首页 - 行情中心 - 华森制药(002907) - 财务分析

华森制药

(002907)

  

流通市值:46.17亿  总市值:57.42亿
流通股本:3.36亿   总股本:4.18亿

华森制药(002907)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.29亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益173611.85万元,未分配利润73455.92万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产203511.48万元,负债29899.63万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入211,846,896.79827,144,563.24625,912,023.87441,913,009.17
营业总成本177,299,368.93767,774,090.85557,825,404.58385,855,057.45
其他经营收益
营业利润37,639,523.293,963,234.13105,996,120.4775,512,477.61
利润总额37,601,107.3777,456,538.1789,546,089.2862,122,793.46
净利润28,907,807.9755,210,478.3867,918,133.1752,286,443.02
每股收益
其他综合收益-65,466.58-394,361.81-49,336.4-17,736.58
综合收益总额28,842,341.3954,816,116.5767,868,796.7752,268,706.44
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,158,496,630.861,128,841,585.981,089,026,686.71,088,649,343.41
非流动资产:
非流动资产合计876,618,124.26898,316,934.73908,674,080.35932,083,668.02
资产总计2,035,114,755.122,027,158,520.711,997,700,767.052,020,733,011.43
流动负债:
流动负债合计247,588,564.66264,440,404.05233,467,375.39256,630,165.59
非流动负债:
非流动负债合计51,407,702.1655,531,310.1854,196,087.755,244,436.17
负债合计298,996,266.82319,971,714.23287,663,463.09311,874,601.76
所有者权益(或股东权益):
归属于母公司股东权益合计1,724,379,055.361,691,321,668.841,688,745,803.431,684,759,062.7
股东权益合计1,736,118,488.31,707,186,806.481,710,037,303.961,708,858,409.67
负债和股东权益合计2,035,114,755.122,027,158,520.711,997,700,767.052,020,733,011.43
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计200,037,203.77839,947,707.16638,169,723.83423,898,088.77
经营活动现金流出小计175,560,654.25777,707,884.69613,377,303.96396,371,750.13
经营活动产生的现金流量净额24,476,549.5262,239,822.4724,792,419.8727,526,338.64
投资活动产生的现金流量:
投资活动现金流入小计202,053,938.73661,941,316.73561,849,047.49231,781,185.5
投资活动现金流出小计204,445,808.87866,557,492.36698,444,809.22404,232,394.94
投资活动产生的现金流量净额-2,391,870.14-204,616,175.63-136,595,761.73-172,451,209.44
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计240,848.5539,742,990.0441,600,936.8726,943,089.87
筹资活动产生的现金流量净额-240,848.55-39,742,990.04-41,600,936.87-26,943,089.87
汇率变动对现金及现金等价物的影响-65,485.02-95,317.35-179,691.37-131,580.48
现金及现金等价物净增加额21,778,345.81-182,214,660.55-153,583,970.1-171,999,541.15
期末现金及现金等价物余额296,115,580.66274,337,234.85302,967,925.3284,552,354.25
补充资料:
现金及现金等价物的净增加额--182,214,660.55--171,999,541.15
TOP↑